AVEO Aveo Pharmaceuticals Inc

Price (delayed)

$5.51

Market cap

$189.33M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2

Enterprise value

$100.94M

Highlights
AVEO's equity has soared by 105% QoQ
The quick ratio has soared by 67% from the previous quarter
The company's gross profit has shrunk by 75% YoY but it rose by 17% QoQ
The revenue has plunged by 74% YoY but it has increased by 19% from the previous quarter
AVEO's debt has surged by 128% since the previous quarter and by 128% year-on-year
Aveo Pharmaceuticals's net income has decreased by 39% QoQ

Key stats

What are the main financial stats of AVEO
Market
Shares outstanding
34.36M
Market cap
$189.33M
Enterprise value
$100.94M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.06
Price to sales (P/S)
21.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.11
Earnings
Revenue
$7.16M
EBIT
-$47.42M
EBITDA
-$47.39M
Free cash flow
-$44.89M
Per share
EPS
-$2
Free cash flow per share
-$1.64
Book value per share
$2.67
Revenue per share
$0.26
TBVPS
$4.65
Balance sheet
Total assets
$127.44M
Total liabilities
$54.99M
Debt
$33.03M
Equity
$72.45M
Working capital
$106.29M
Liquidity
Debt to equity
0.46
Current ratio
6.38
Quick ratio
6.2
Net debt/EBITDA
1.87
Margins
EBITDA margin
-662.3%
Gross margin
98.1%
Net margin
-689.4%
Operating margin
-660.8%
Efficiency
Return on assets
-57.5%
Return on equity
-100.7%
Return on invested capital
-259.6%
Return on capital employed
-44%
Return on sales
-662.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVEO stock price

How has the Aveo Pharmaceuticals stock price performed over time
Intraday
5.15%
1 week
6.99%
1 month
-11.98%
1 year
24.1%
YTD
-4.51%
QTD
-16.39%

Financial performance

How have Aveo Pharmaceuticals's revenue and profit performed over time
Revenue
$7.16M
Gross profit
$7.02M
Operating income
-$47.28M
Net income
-$49.33M
Gross margin
98.1%
Net margin
-689.4%
The company's gross profit has shrunk by 75% YoY but it rose by 17% QoQ
The revenue has plunged by 74% YoY but it has increased by 19% from the previous quarter
Aveo Pharmaceuticals's net income has decreased by 39% QoQ
The company's operating income fell by 22% QoQ

Growth

What is Aveo Pharmaceuticals's growth rate over time

Valuation

What is Aveo Pharmaceuticals stock price valuation
P/E
N/A
P/B
2.06
P/S
21.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.11
The company's EPS fell by 20% QoQ
AVEO's equity has soared by 105% QoQ
The P/B is 39% lower than the last 4 quarters average of 3.2
The revenue has plunged by 74% YoY but it has increased by 19% from the previous quarter
The price to sales (P/S) is 31% lower than the 5-year quarterly average of 29.1 but 3.6% higher than the last 4 quarters average of 19.4

Efficiency

How efficient is Aveo Pharmaceuticals business performance
The return on invested capital has declined by 17% since the previous quarter
The company's return on sales fell by 17% QoQ
The ROE has grown by 8% from the previous quarter
AVEO's ROA is down by 2.7% QoQ

Dividends

What is AVEO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVEO.

Financial health

How did Aveo Pharmaceuticals financials performed over time
The total assets is 132% greater than the total liabilities
The total assets has surged by 90% since the previous quarter
The company's total liabilities has surged by 74% YoY and by 74% QoQ
AVEO's debt is 54% smaller than its equity
AVEO's debt has surged by 128% since the previous quarter and by 128% year-on-year
AVEO's equity has soared by 105% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.